- Investigator-initiated study includes leading researchers in SCD gene therapy clinical development from St. Jude Children's Research Hospital, Inc. and two other clinical sites -   - New trial to expand ongoing clinical research of motixafortide for mobilization of HSCs in patients with SCD - TEL AVIV, Israel , May 30, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced a multi-center Phase 1 clinical trial sponsored  by St. Jude Children's Research Hospital, Inc. to evaluate motixafortide for the mobilization of CD34+ hematopoietic stem cells (HSCs) used in the development of gene therapies for patients with sickle cell disease (SCD).

05/30/2024

Panagora Asset Management Inc. bought a new stake in Enviri Co. (NYSE:NVRI – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 347,073 shares of the company’s stock, valued at approximately $3,124,000. Panagora Asset Management Inc. owned 0.43% of Enviri as of its most recent filing with the Securities and Exchange Commission. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Diversified Trust Co bought a new position in Enviri in the fourth quarter valued at approximately $104,000. Brookstone Capital Management bought a new position in Enviri during the fourth quarter worth about $144,000. Legato Capital Management LLC acquired a new position in shares of Enviri during the 4th quarter worth about $1,212,000. D.B. Root & Company LLC bought a new stake in shares of Enviri in the 4th quarter valued at about $477,000. Finally, State of Alaska Department of Revenue bought a new position in Enviri during the 4th quarter worth approximately $442,000. 93.43% of the stock is owned by institutional investors. Insider Activity In related news, CEO F Nicholas Grasberger III bought 25,000 shares of the stock in a transaction that occurred on Monday, May 6th. The shares were acquired at an average price of $7.59 per share, with a total value of $189,750.00. Following the completion of the transaction, the chief executive officer now owns 837,901 shares in the company, valued at $6,359,668.59. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.70% of the company’s stock. Enviri Stock Performance Shares of NYSE NVRI opened at $8.24 on Monday. The firm has a 50 day moving average price of $8.26 and a 200 day moving average price of $7.94. The company has a debt-to-equity ratio of 2.65, a quick ratio of 1.03 and a current ratio of 1.36. Enviri Co. has a 52-week low of $5.64 and a 52-week high of $10.01. Enviri (NYSE:NVRI – Get Free Report) last released its quarterly earnings data on Thursday, May 2nd. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.06. Enviri had a negative net margin of 4.35% and a negative return on equity of 0.99%. The business had revenue of $600.00 million during the quarter, compared to analysts’ expectations of $509.77 million. During the same quarter in the prior year, the company earned ($0.11) EPS. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. On average, sell-side analysts forecast that Enviri Co. will post 0.01 EPS for the current year. About Enviri (Free Report) Enviri Corporation provides environmental solutions for industrial and specialty waste streams in the United States and internationally. The company operates through two segments: Harsco Environmental and Clean Earth. The Harsco Environmental segment offers on-site services under long-term contracts for material logistics, product quality improvement, and resource recovery for iron, steel, and metals manufacturing; manufactures and sells industrial abrasives, roofing granules, aluminum dross, and scrap processing systems; and meltshop and furnace services, such as under-vessel cleaning, removal of ladle slag, and general melt shop debris. See Also Five stocks we like better than Enviri Overbought Stocks Explained: Should You Trade Them? Canada Goose Flies Higher Driven By DTC Growth Best Aerospace Stocks Investing CVS Health Stock Has a Silver Lining Called Value What Are Dividend Contenders? Investing in Dividend Contenders Magnificent 7 Still Magnificent as the Halfway Mark Approaches? Want to see what other hedge funds are holding NVRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enviri Co. (NYSE:NVRI – Free Report).

05/20/2024